News

Improved understanding of how bacterial defense mechanisms operate may help scientists select phages with the best chance of ...
Preexisting immunity to the 2009 H1N1 influenza virus provided near-complete protection against severe H5N1 disease and ...
Assembly Biosciences, Inc. (NASDAQ: ASMB) is one of the growth stocks that could double by 2027. On June 25, the company ...
Got junk? Learn how a new study suggests that, when it comes to our genetic code, that may actually be a good thing.
Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than ...
Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment ...
Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...
A new study provides a detailed structure of a human enzyme critical for antiviral defense and platelet function.
Many known viruses pose a continuing threat to public health, and we are constantly dealing with the possibility that new viruses could emerge .. | Microbiology ...
Misperceptions around a vaccine’s plaque-forming unit (PFU) level are leading to inaccurate conclusions about vaccine protection ...
Severe fever with thrombocytopenia syndrome (SFTS) was reported in Asia, with a fatality rate that can reach as high as 50%.